Mechanistic studies in experimental models of disease have shown that MIF contributes to insulin function in non-pathological glucose homeostasis (i.e., in absence of obesity or disease) but its role is less clear when metabolic stress and pathological processes come into play. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.